Literature DB >> 16966582

Functional expression of the TRPM4 cationic current in ventricular cardiomyocytes from spontaneously hypertensive rats.

Romain Guinamard1, Marie Demion, Christophe Magaud, Daniel Potreau, Patrick Bois.   

Abstract

Cardiac hypertrophy is associated with electrophysiological modifications, including modification of action potential shape that can give rise to arrhythmias. We report here a higher detection of a calcium-activated nonselective cation current in cardiomyocytes of spontaneously hypertensive rats (SHRs), a model of hypertension and heart hypertrophy when compared with Wistar-Kyoto (WKY) rat, its normotensive equivalent. Freshly isolated cells from the left ventricles of 3- to 6-month-old WKY rats or SHRs were used for patch-clamp recordings. In inside-out patches, the channel presented a linear conductance of 25+/-0.5 pS, did not discriminate Na(+) over K(+), and was not permeable to Ca(2+). Open probability was increased by depolarization and a rise in [Ca(2+)](i) (dissociation constant=10+/-5.4 micromol/L) but reduced by 0.5 mmol/L [ATP](i), 10 micromol/L glibenclamide, or flufenamic acid (IC(50)=5.5+/-1.7 micromol/L). Thus, it owns the fingerprint of the TRPM4 current. Although rarely detected in WKY cardiomyocytes, the current was present in >50% of patches from SHR cardiomyocytes. Moreover, by performing RT-PCR from ventricular samples, we observed that TRPM4 mRNA detection was higher in SHRs than in WKY rats. We propose that a TRPM4 current is expressed in ventricular cardiomyocytes from SHRs. According to its properties, this channel may contribute to the transient inward current implicated in delayed-after-depolarizations observed during [Ca(2+)] overload of cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16966582     DOI: 10.1161/01.HYP.0000237864.65019.a5

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  48 in total

Review 1.  Emerging concepts for the role of TRP channels in the cardiovascular system.

Authors:  Rudi Vennekens
Journal:  J Physiol       Date:  2010-12-20       Impact factor: 5.182

2.  Transient receptor potential melastatin 4 inhibitor 9-phenanthrol abolishes arrhythmias induced by hypoxia and re-oxygenation in mouse ventricle.

Authors:  Christophe Simard; Laurent Sallé; René Rouet; Romain Guinamard
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 3.  Transient receptor potential channels in the vasculature.

Authors:  Scott Earley; Joseph E Brayden
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

4.  Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice.

Authors:  Ilka Mathar; Rudi Vennekens; Marcel Meissner; Frieder Kees; Gerry Van der Mieren; Juan E Camacho Londoño; Sebastian Uhl; Thomas Voets; Björn Hummel; An van den Bergh; Paul Herijgers; Bernd Nilius; Veit Flockerzi; Frank Schweda; Marc Freichel
Journal:  J Clin Invest       Date:  2010-08-02       Impact factor: 14.808

5.  Characterizing the conductance underlying depolarization-induced slow current in cerebellar Purkinje cells.

Authors:  Yu Shin Kim; Eunchai Kang; Yuichi Makino; Sungjin Park; Jung Hoon Shin; Hongjun Song; Pierre Launay; David J Linden
Journal:  J Neurophysiol       Date:  2012-11-28       Impact factor: 2.714

6.  Transient receptor potential vanilloid-4 contributes to stretch-induced hypercontractility and time-dependent dysfunction in the aged heart.

Authors:  Adam B Veteto; Deborah Peana; Michelle D Lambert; Kerry S McDonald; Timothy L Domeier
Journal:  Cardiovasc Res       Date:  2020-09-01       Impact factor: 10.787

Review 7.  The TRPM4 channel inhibitor 9-phenanthrol.

Authors:  R Guinamard; T Hof; C A Del Negro
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

8.  TRPM4 inhibition promotes angiogenesis after ischemic stroke.

Authors:  Kok Poh Loh; Gandi Ng; Chye Yun Yu; Chee Kong Fhu; Dejie Yu; Rudi Vennekens; Bernd Nilius; Tuck Wah Soong; Ping Liao
Journal:  Pflugers Arch       Date:  2013-09-17       Impact factor: 3.657

Review 9.  TRPM4 channels in smooth muscle function.

Authors:  Scott Earley
Journal:  Pflugers Arch       Date:  2013-02-27       Impact factor: 3.657

10.  9-phenanthrol inhibits human TRPM4 but not TRPM5 cationic channels.

Authors:  T Grand; M Demion; C Norez; Y Mettey; P Launay; F Becq; P Bois; R Guinamard
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.